Connection

F. BLAINE HOLLINGER to Humans

This is a "connection" page, showing publications F. BLAINE HOLLINGER has written about Humans.
Connection Strength

0.279
  1. GSK-3? as a Potential Coordinator of Anabolic and Catabolic Pathways in Hepatitis C Virus Insulin Resistance. Intervirology. 2024; 67(1):6-18.
    View in: PubMed
    Score: 0.025
  2. Impact of "a" determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B. J Med Virol. 2017 10; 89(10):1796-1803.
    View in: PubMed
    Score: 0.016
  3. Is the Risk of Death Enhanced in Immunosuppressed Hepatitis B?Virus-infected Patients Who Develop Acute Liver Failure? Clin Gastroenterol Hepatol. 2017 01; 15(1):123-126.
    View in: PubMed
    Score: 0.015
  4. Should Evidence-based Medicine Be Used to Design Clinical Practice Guidelines for the Prevention of Perinatal Transmission of Hepatitis B Virus From Hepatitis B e Antigen-Positive Mothers? Clin Gastroenterol Hepatol. 2015 Jun; 13(6):1177-80.
    View in: PubMed
    Score: 0.013
  5. Use of Hy's Law, R criteria, and nR criteria to predict acute liver failure or transplantation in patients with drug-induced liver injury. Gastroenterology. 2015 Feb; 148(2):452.
    View in: PubMed
    Score: 0.013
  6. Molecular pathways for glucose homeostasis, insulin signaling and autophagy in hepatitis C virus induced insulin resistance in a cellular model. Virology. 2012 Dec 05; 434(1):5-17.
    View in: PubMed
    Score: 0.011
  7. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010 Jan; 17(1):1-15.
    View in: PubMed
    Score: 0.009
  8. Hepatitis B virus traceback and lookback: factors to consider. Transfusion. 2009 Jan; 49(1):176-84.
    View in: PubMed
    Score: 0.009
  9. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008 May; 48(5):1001-26.
    View in: PubMed
    Score: 0.008
  10. Hepatitis A and B vaccination and public health. J Viral Hepat. 2007 Nov; 14 Suppl 1:1-5.
    View in: PubMed
    Score: 0.008
  11. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat. 2007 Nov; 14 Suppl 1:11-5.
    View in: PubMed
    Score: 0.008
  12. Hepatitis B: the pathway to recovery through treatment. Gastroenterol Clin North Am. 2006 Jun; 35(2):425-61, x.
    View in: PubMed
    Score: 0.007
  13. Hepatitis C virus (HCV) occult infection or occult HCV RNA detection? J Infect Dis. 2004 Jan 01; 189(1):3-6.
    View in: PubMed
    Score: 0.006
  14. Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives. Transfusion. 2003 Aug; 43(8):992-7.
    View in: PubMed
    Score: 0.006
  15. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time. Hepatology. 2001 Aug; 34(2):424-9.
    View in: PubMed
    Score: 0.005
  16. Use of human tissue stem cell-derived organoid cultures to model enterohepatic circulation. Am J Physiol Gastrointest Liver Physiol. 2021 09 01; 321(3):G270-G279.
    View in: PubMed
    Score: 0.005
  17. Long-term culture of human immunodeficiency virus type 1 resulting in loss of glycosylation sites. J Med Virol. 2001 Mar; 63(3):197-202.
    View in: PubMed
    Score: 0.005
  18. Sleeping Beauty and Hepatitis B: An Evidence-Based Guide for Dermatologists. Skinmed. 2021; 19(1):37-41.
    View in: PubMed
    Score: 0.005
  19. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020 10; 73(4):952-964.
    View in: PubMed
    Score: 0.005
  20. Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex. Cells. 2020 03 30; 9(4).
    View in: PubMed
    Score: 0.005
  21. Factors contributing to the evolution and outcome of cirrhosis in hepatitis C. Clin Liver Dis. 1999 Nov; 3(4):741-55, viii.
    View in: PubMed
    Score: 0.005
  22. Selection of appropriate HIV-1 genomic regions for single-strand conformation polymorphism analysis of the diversity, modification, and transmission of HIV-1 quasispecies. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):409-16.
    View in: PubMed
    Score: 0.004
  23. Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 1998 Mar; 36(3):835-9.
    View in: PubMed
    Score: 0.004
  24. Overview of viral hepatitis. Int J Circumpolar Health. 1998; 57 Suppl 1:276-9.
    View in: PubMed
    Score: 0.004
  25. Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products. J Med Virol. 1997 Jan; 51(1):56-63.
    View in: PubMed
    Score: 0.004
  26. Detection of antibodies to hepatitis C virus in seronegative patients using an immune complex dissociation assay. J Viral Hepat. 1997; 4(6):383-6.
    View in: PubMed
    Score: 0.004
  27. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA. J Clin Microbiol. 1996 Feb; 34(2):329-33.
    View in: PubMed
    Score: 0.004
  28. Comprehensive control (or elimination) of hepatitis B virus transmission in the United States. Gut. 1996; 38 Suppl 2:S24-30.
    View in: PubMed
    Score: 0.004
  29. Life span of circulating membrane CD4 inserted into the plasma membranes of autologous red blood cells of HIV-infected subjects. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 01; 9(2):126-32.
    View in: PubMed
    Score: 0.003
  30. Single-strand conformation polymorphism study of human immunodeficiency virus type 1 RNA and DNA in plasma, peripheral blood mononuclear cells, and their virologic cultures. J Infect Dis. 1995 Jun; 171(6):1619-22.
    View in: PubMed
    Score: 0.003
  31. Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States. J Infect Dis. 1995 Mar; 171 Suppl 1:S73-7.
    View in: PubMed
    Score: 0.003
  32. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B. J Med Virol. 2013 Jun; 85(6):979-86.
    View in: PubMed
    Score: 0.003
  33. Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs. J Med Virol. 1992 Nov; 38(3):220-5.
    View in: PubMed
    Score: 0.003
  34. Bleeding from a Meckel's diverticulum after the use of ibuprofen. Am J Gastroenterol. 1992 Oct; 87(10):1467-70.
    View in: PubMed
    Score: 0.003
  35. Transcriptional activity of HIV-1 and HHV-6 in retinal lesions from AIDS patients. Invest Ophthalmol Vis Sci. 1992 Sep; 33(10):2759-67.
    View in: PubMed
    Score: 0.003
  36. Frequency of dual infections of corneas with HIV-1 and HHV-6. Curr Eye Res. 1992 Apr; 11(4):315-23.
    View in: PubMed
    Score: 0.003
  37. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med. 2011 Jan 20; 364(3):236-47.
    View in: PubMed
    Score: 0.003
  38. Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force. Transfusion. 2011 Mar; 51(3):654-61.
    View in: PubMed
    Score: 0.003
  39. Microculture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells. J Clin Microbiol. 1990 Apr; 28(4):734-7.
    View in: PubMed
    Score: 0.002
  40. Controlling hepatitis B virus transmission in North America. The North American Regional Study Group. Vaccine. 1990 Mar; 8 Suppl:S122-8; discussion S134-8.
    View in: PubMed
    Score: 0.002
  41. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med. 1989 Sep 04; 87(3A):36S-40S.
    View in: PubMed
    Score: 0.002
  42. In vivo and in vitro ultrastructural alterations induced by human immunodeficiency virus in human lymphoid cells. Lab Invest. 1989 Sep; 61(3):303-9.
    View in: PubMed
    Score: 0.002
  43. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009 Aug; 49 Suppl 2:1S-29S.
    View in: PubMed
    Score: 0.002
  44. Hepatitis B virus infection and renal transplantation. Hepatology. 1988 Sep-Oct; 8(5):1172-4.
    View in: PubMed
    Score: 0.002
  45. Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C. Liver Int. 2007 Oct; 27(8):1111-8.
    View in: PubMed
    Score: 0.002
  46. Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan. World J Gastroenterol. 2007 Feb 28; 13(8):1204-7.
    View in: PubMed
    Score: 0.002
  47. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation. Transfusion. 2004 Aug; 44(8):1179-85.
    View in: PubMed
    Score: 0.002
  48. Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg. 2002 Aug; 67(2):201-6.
    View in: PubMed
    Score: 0.001
  49. Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission. J Acquir Immune Defic Syndr. 2002 May 01; 30(1):88-94.
    View in: PubMed
    Score: 0.001
  50. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules. Vaccine. 1997 Oct; 15(15):1613-7.
    View in: PubMed
    Score: 0.001
  51. HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the absence of human cytomegalovirus. Invest Ophthalmol Vis Sci. 1995 Sep; 36(10):2040-7.
    View in: PubMed
    Score: 0.001
  52. Sensitivity of immune complex-dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants. Clin Diagn Lab Immunol. 1995 Jan; 2(1):87-90.
    View in: PubMed
    Score: 0.001
  53. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis. 1994 Sep; 170(3):553-62.
    View in: PubMed
    Score: 0.001
  54. A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1994 Feb; 13(2):90-4.
    View in: PubMed
    Score: 0.001
  55. Southern-blot analysis and simultaneous in situ detection of hepatitis B virus-associated DNA and antigens in patients with end-stage liver disease. Hepatology. 1993 Nov; 18(5):1032-8.
    View in: PubMed
    Score: 0.001
  56. Study of human immunodeficiency virus resistance to 2'-3'-dideoxyinosine and zidovudine in sequential isolates from pediatric patients on long-term therapy. J Infect Dis. 1993 Apr; 167(4):818-23.
    View in: PubMed
    Score: 0.001
  57. A multicenter study of viral hepatitis in a United States hemophilic population. Blood. 1993 Jan 15; 81(2):412-8.
    View in: PubMed
    Score: 0.001
  58. Sensitivity, specificity and predictive value of physical examination, culture and other laboratory studies in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1993 Jan; 12(1):33-6.
    View in: PubMed
    Score: 0.001
  59. Simultaneous detection of HBV-specific antigens and DNA in paraffin-embedded liver tissue by immunohistochemistry and in situ hybridization using a digoxigenin-labeled probe. J Virol Methods. 1992 Apr; 37(1):89-97.
    View in: PubMed
    Score: 0.001
  60. The incidence of HIV-1 and HHV-6 in corneal buttons. Curr Eye Res. 1991; 10 Suppl:97-103.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.